Global Veterinary Immunomodulators Market Growth 2026-2032
The global Veterinary Immunomodulators market size is predicted to grow from US$ 1204 million in 2025 to US$ 1775 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
Veterinary Immunomodulators are substances or drugs used to regulate or modify the immune system of animals. They are typically used in veterinary medicine to enhance or suppress the immune response in animals that are suffering from immune-related disorders or infections. Immunomodulators can help boost the animal's ability to fight infections, control autoimmune diseases, or regulate allergic reactions. They are often prescribed when an animal's immune system is either underactive (leading to infections) or overactive (leading to autoimmune or inflammatory diseases).
United States market for Veterinary Immunomodulators is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Veterinary Immunomodulators is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Veterinary Immunomodulators is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Veterinary Immunomodulators players cover Zoetis, Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, MSD Animal Health, ImmunoVet Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Veterinary Immunomodulators Industry Forecast? looks at past sales and reviews total world Veterinary Immunomodulators sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Immunomodulators sales for 2026 through 2032. With Veterinary Immunomodulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Immunomodulators industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Immunomodulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Immunomodulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Immunomodulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Immunomodulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Immunomodulators.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Immunomodulators market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Veterinary Immunomodulators market?
What factors are driving Veterinary Immunomodulators market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Immunomodulators market opportunities vary by end market size?
How does Veterinary Immunomodulators break out by Type, by Application?
Veterinary Immunomodulators are substances or drugs used to regulate or modify the immune system of animals. They are typically used in veterinary medicine to enhance or suppress the immune response in animals that are suffering from immune-related disorders or infections. Immunomodulators can help boost the animal's ability to fight infections, control autoimmune diseases, or regulate allergic reactions. They are often prescribed when an animal's immune system is either underactive (leading to infections) or overactive (leading to autoimmune or inflammatory diseases).
United States market for Veterinary Immunomodulators is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Veterinary Immunomodulators is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Veterinary Immunomodulators is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Veterinary Immunomodulators players cover Zoetis, Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, MSD Animal Health, ImmunoVet Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Veterinary Immunomodulators Industry Forecast? looks at past sales and reviews total world Veterinary Immunomodulators sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Immunomodulators sales for 2026 through 2032. With Veterinary Immunomodulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Immunomodulators industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Immunomodulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Immunomodulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Immunomodulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Immunomodulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Immunomodulators.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Immunomodulators market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Injectable
- Topical
- Others
- Online Sales
- Offline Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis, Inc.
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- MSD Animal Health
- ImmunoVet Ltd.
- Vetoquinol S.A.
- Phibro Animal Health Corporation
- Ceva Sant? Animale
- Biogenesis Bago
What is the 10-year outlook for the global Veterinary Immunomodulators market?
What factors are driving Veterinary Immunomodulators market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Immunomodulators market opportunities vary by end market size?
How does Veterinary Immunomodulators break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Immunomodulators Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Veterinary Immunomodulators by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Veterinary Immunomodulators by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Immunomodulators Segment by Type
2.2.1 Oral
2.2.2 Injectable
2.2.3 Topical
2.2.4 Others
2.2.5 Veterinary Immunomodulators Sales by Type
2.2.5.1 Global Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
2.2.5.2 Global Veterinary Immunomodulators Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Veterinary Immunomodulators Sale Price by Type (2021-2026)
2.3 Veterinary Immunomodulators Segment by Application
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Veterinary Immunomodulators Sales by Application
2.3.3.1 Global Veterinary Immunomodulators Sale Market Share by Application (2021-2026)
2.3.3.2 Global Veterinary Immunomodulators Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Veterinary Immunomodulators Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Immunomodulators Breakdown Data by Company
3.1.1 Global Veterinary Immunomodulators Annual Sales by Company (2021-2026)
3.1.2 Global Veterinary Immunomodulators Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Immunomodulators Annual Revenue by Company (2021-2026)
3.2.1 Global Veterinary Immunomodulators Revenue by Company (2021-2026)
3.2.2 Global Veterinary Immunomodulators Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Immunomodulators Sale Price by Company
3.4 Key Manufacturers Veterinary Immunomodulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Immunomodulators Product Location Distribution
3.4.2 Players Veterinary Immunomodulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY IMMUNOMODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Immunomodulators Market Size by Geographic Region (2021-2026)
4.1.1 Global Veterinary Immunomodulators Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Veterinary Immunomodulators Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Immunomodulators Market Size by Country/Region (2021-2026)
4.2.1 Global Veterinary Immunomodulators Annual Sales by Country/Region (2021-2026)
4.2.2 Global Veterinary Immunomodulators Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Immunomodulators Sales Growth
4.4 APAC Veterinary Immunomodulators Sales Growth
4.5 Europe Veterinary Immunomodulators Sales Growth
4.6 Middle East & Africa Veterinary Immunomodulators Sales Growth
5 AMERICAS
5.1 Americas Veterinary Immunomodulators Sales by Country
5.1.1 Americas Veterinary Immunomodulators Sales by Country (2021-2026)
5.1.2 Americas Veterinary Immunomodulators Revenue by Country (2021-2026)
5.2 Americas Veterinary Immunomodulators Sales by Type (2021-2026)
5.3 Americas Veterinary Immunomodulators Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Immunomodulators Sales by Region
6.1.1 APAC Veterinary Immunomodulators Sales by Region (2021-2026)
6.1.2 APAC Veterinary Immunomodulators Revenue by Region (2021-2026)
6.2 APAC Veterinary Immunomodulators Sales by Type (2021-2026)
6.3 APAC Veterinary Immunomodulators Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Immunomodulators by Country
7.1.1 Europe Veterinary Immunomodulators Sales by Country (2021-2026)
7.1.2 Europe Veterinary Immunomodulators Revenue by Country (2021-2026)
7.2 Europe Veterinary Immunomodulators Sales by Type (2021-2026)
7.3 Europe Veterinary Immunomodulators Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Immunomodulators by Country
8.1.1 Middle East & Africa Veterinary Immunomodulators Sales by Country (2021-2026)
8.1.2 Middle East & Africa Veterinary Immunomodulators Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Immunomodulators Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Immunomodulators Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Immunomodulators
10.3 Manufacturing Process Analysis of Veterinary Immunomodulators
10.4 Industry Chain Structure of Veterinary Immunomodulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Immunomodulators Distributors
11.3 Veterinary Immunomodulators Customer
12 WORLD FORECAST REVIEW FOR VETERINARY IMMUNOMODULATORS BY GEOGRAPHIC REGION
12.1 Global Veterinary Immunomodulators Market Size Forecast by Region
12.1.1 Global Veterinary Immunomodulators Forecast by Region (2027-2032)
12.1.2 Global Veterinary Immunomodulators Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Immunomodulators Forecast by Type (2027-2032)
12.7 Global Veterinary Immunomodulators Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis, Inc.
13.1.1 Zoetis, Inc. Company Information
13.1.2 Zoetis, Inc. Veterinary Immunomodulators Product Portfolios and Specifications
13.1.3 Zoetis, Inc. Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis, Inc. Main Business Overview
13.1.5 Zoetis, Inc. Latest Developments
13.2 Elanco Animal Health
13.2.1 Elanco Animal Health Company Information
13.2.2 Elanco Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
13.2.3 Elanco Animal Health Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Elanco Animal Health Main Business Overview
13.2.5 Elanco Animal Health Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
13.4.3 MSD Animal Health Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
13.5 ImmunoVet Ltd.
13.5.1 ImmunoVet Ltd. Company Information
13.5.2 ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolios and Specifications
13.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ImmunoVet Ltd. Main Business Overview
13.5.5 ImmunoVet Ltd. Latest Developments
13.6 Vetoquinol S.A.
13.6.1 Vetoquinol S.A. Company Information
13.6.2 Vetoquinol S.A. Veterinary Immunomodulators Product Portfolios and Specifications
13.6.3 Vetoquinol S.A. Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Vetoquinol S.A. Main Business Overview
13.6.5 Vetoquinol S.A. Latest Developments
13.7 Phibro Animal Health Corporation
13.7.1 Phibro Animal Health Corporation Company Information
13.7.2 Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolios and Specifications
13.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Phibro Animal Health Corporation Main Business Overview
13.7.5 Phibro Animal Health Corporation Latest Developments
13.8 Ceva Sant? Animale
13.8.1 Ceva Sant? Animale Company Information
13.8.2 Ceva Sant? Animale Veterinary Immunomodulators Product Portfolios and Specifications
13.8.3 Ceva Sant? Animale Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ceva Sant? Animale Main Business Overview
13.8.5 Ceva Sant? Animale Latest Developments
13.9 Biogenesis Bago
13.9.1 Biogenesis Bago Company Information
13.9.2 Biogenesis Bago Veterinary Immunomodulators Product Portfolios and Specifications
13.9.3 Biogenesis Bago Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biogenesis Bago Main Business Overview
13.9.5 Biogenesis Bago Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Immunomodulators Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Veterinary Immunomodulators by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Veterinary Immunomodulators by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Immunomodulators Segment by Type
2.2.1 Oral
2.2.2 Injectable
2.2.3 Topical
2.2.4 Others
2.2.5 Veterinary Immunomodulators Sales by Type
2.2.5.1 Global Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
2.2.5.2 Global Veterinary Immunomodulators Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Veterinary Immunomodulators Sale Price by Type (2021-2026)
2.3 Veterinary Immunomodulators Segment by Application
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Veterinary Immunomodulators Sales by Application
2.3.3.1 Global Veterinary Immunomodulators Sale Market Share by Application (2021-2026)
2.3.3.2 Global Veterinary Immunomodulators Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Veterinary Immunomodulators Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Immunomodulators Breakdown Data by Company
3.1.1 Global Veterinary Immunomodulators Annual Sales by Company (2021-2026)
3.1.2 Global Veterinary Immunomodulators Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Immunomodulators Annual Revenue by Company (2021-2026)
3.2.1 Global Veterinary Immunomodulators Revenue by Company (2021-2026)
3.2.2 Global Veterinary Immunomodulators Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Immunomodulators Sale Price by Company
3.4 Key Manufacturers Veterinary Immunomodulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Immunomodulators Product Location Distribution
3.4.2 Players Veterinary Immunomodulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY IMMUNOMODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Immunomodulators Market Size by Geographic Region (2021-2026)
4.1.1 Global Veterinary Immunomodulators Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Veterinary Immunomodulators Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Immunomodulators Market Size by Country/Region (2021-2026)
4.2.1 Global Veterinary Immunomodulators Annual Sales by Country/Region (2021-2026)
4.2.2 Global Veterinary Immunomodulators Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Immunomodulators Sales Growth
4.4 APAC Veterinary Immunomodulators Sales Growth
4.5 Europe Veterinary Immunomodulators Sales Growth
4.6 Middle East & Africa Veterinary Immunomodulators Sales Growth
5 AMERICAS
5.1 Americas Veterinary Immunomodulators Sales by Country
5.1.1 Americas Veterinary Immunomodulators Sales by Country (2021-2026)
5.1.2 Americas Veterinary Immunomodulators Revenue by Country (2021-2026)
5.2 Americas Veterinary Immunomodulators Sales by Type (2021-2026)
5.3 Americas Veterinary Immunomodulators Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Immunomodulators Sales by Region
6.1.1 APAC Veterinary Immunomodulators Sales by Region (2021-2026)
6.1.2 APAC Veterinary Immunomodulators Revenue by Region (2021-2026)
6.2 APAC Veterinary Immunomodulators Sales by Type (2021-2026)
6.3 APAC Veterinary Immunomodulators Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Immunomodulators by Country
7.1.1 Europe Veterinary Immunomodulators Sales by Country (2021-2026)
7.1.2 Europe Veterinary Immunomodulators Revenue by Country (2021-2026)
7.2 Europe Veterinary Immunomodulators Sales by Type (2021-2026)
7.3 Europe Veterinary Immunomodulators Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Immunomodulators by Country
8.1.1 Middle East & Africa Veterinary Immunomodulators Sales by Country (2021-2026)
8.1.2 Middle East & Africa Veterinary Immunomodulators Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Immunomodulators Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Immunomodulators Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Immunomodulators
10.3 Manufacturing Process Analysis of Veterinary Immunomodulators
10.4 Industry Chain Structure of Veterinary Immunomodulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Immunomodulators Distributors
11.3 Veterinary Immunomodulators Customer
12 WORLD FORECAST REVIEW FOR VETERINARY IMMUNOMODULATORS BY GEOGRAPHIC REGION
12.1 Global Veterinary Immunomodulators Market Size Forecast by Region
12.1.1 Global Veterinary Immunomodulators Forecast by Region (2027-2032)
12.1.2 Global Veterinary Immunomodulators Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Immunomodulators Forecast by Type (2027-2032)
12.7 Global Veterinary Immunomodulators Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis, Inc.
13.1.1 Zoetis, Inc. Company Information
13.1.2 Zoetis, Inc. Veterinary Immunomodulators Product Portfolios and Specifications
13.1.3 Zoetis, Inc. Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis, Inc. Main Business Overview
13.1.5 Zoetis, Inc. Latest Developments
13.2 Elanco Animal Health
13.2.1 Elanco Animal Health Company Information
13.2.2 Elanco Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
13.2.3 Elanco Animal Health Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Elanco Animal Health Main Business Overview
13.2.5 Elanco Animal Health Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
13.4.3 MSD Animal Health Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
13.5 ImmunoVet Ltd.
13.5.1 ImmunoVet Ltd. Company Information
13.5.2 ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolios and Specifications
13.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ImmunoVet Ltd. Main Business Overview
13.5.5 ImmunoVet Ltd. Latest Developments
13.6 Vetoquinol S.A.
13.6.1 Vetoquinol S.A. Company Information
13.6.2 Vetoquinol S.A. Veterinary Immunomodulators Product Portfolios and Specifications
13.6.3 Vetoquinol S.A. Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Vetoquinol S.A. Main Business Overview
13.6.5 Vetoquinol S.A. Latest Developments
13.7 Phibro Animal Health Corporation
13.7.1 Phibro Animal Health Corporation Company Information
13.7.2 Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolios and Specifications
13.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Phibro Animal Health Corporation Main Business Overview
13.7.5 Phibro Animal Health Corporation Latest Developments
13.8 Ceva Sant? Animale
13.8.1 Ceva Sant? Animale Company Information
13.8.2 Ceva Sant? Animale Veterinary Immunomodulators Product Portfolios and Specifications
13.8.3 Ceva Sant? Animale Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ceva Sant? Animale Main Business Overview
13.8.5 Ceva Sant? Animale Latest Developments
13.9 Biogenesis Bago
13.9.1 Biogenesis Bago Company Information
13.9.2 Biogenesis Bago Veterinary Immunomodulators Product Portfolios and Specifications
13.9.3 Biogenesis Bago Veterinary Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biogenesis Bago Main Business Overview
13.9.5 Biogenesis Bago Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Immunomodulators Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Immunomodulators Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Major Players of Topical
Table 6. Major Players of Others
Table 7. Global Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 8. Global Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Table 9. Global Veterinary Immunomodulators Revenue by Type (2021-2026) & ($ million)
Table 10. Global Veterinary Immunomodulators Revenue Market Share by Type (2021-2026)
Table 11. Global Veterinary Immunomodulators Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global Veterinary Immunomodulators Sale by Application (2021-2026) & (kg)
Table 13. Global Veterinary Immunomodulators Sale Market Share by Application (2021-2026)
Table 14. Global Veterinary Immunomodulators Revenue by Application (2021-2026) & ($ million)
Table 15. Global Veterinary Immunomodulators Revenue Market Share by Application (2021-2026)
Table 16. Global Veterinary Immunomodulators Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global Veterinary Immunomodulators Sales by Company (2021-2026) & (kg)
Table 18. Global Veterinary Immunomodulators Sales Market Share by Company (2021-2026)
Table 19. Global Veterinary Immunomodulators Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Veterinary Immunomodulators Revenue Market Share by Company (2021-2026)
Table 21. Global Veterinary Immunomodulators Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers Veterinary Immunomodulators Producing Area Distribution and Sales Area
Table 23. Players Veterinary Immunomodulators Products Offered
Table 24. Veterinary Immunomodulators Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Veterinary Immunomodulators Sales by Geographic Region (2021-2026) & (kg)
Table 28. Global Veterinary Immunomodulators Sales Market Share Geographic Region (2021-2026)
Table 29. Global Veterinary Immunomodulators Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Veterinary Immunomodulators Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Veterinary Immunomodulators Sales by Country/Region (2021-2026) & (kg)
Table 32. Global Veterinary Immunomodulators Sales Market Share by Country/Region (2021-2026)
Table 33. Global Veterinary Immunomodulators Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Veterinary Immunomodulators Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Veterinary Immunomodulators Sales by Country (2021-2026) & (kg)
Table 36. Americas Veterinary Immunomodulators Sales Market Share by Country (2021-2026)
Table 37. Americas Veterinary Immunomodulators Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 39. Americas Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 40. APAC Veterinary Immunomodulators Sales by Region (2021-2026) & (kg)
Table 41. APAC Veterinary Immunomodulators Sales Market Share by Region (2021-2026)
Table 42. APAC Veterinary Immunomodulators Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 44. APAC Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 45. Europe Veterinary Immunomodulators Sales by Country (2021-2026) & (kg)
Table 46. Europe Veterinary Immunomodulators Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 48. Europe Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 49. Middle East & Africa Veterinary Immunomodulators Sales by Country (2021-2026) & (kg)
Table 50. Middle East & Africa Veterinary Immunomodulators Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 52. Middle East & Africa Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 53. Key Market Drivers & Growth Opportunities of Veterinary Immunomodulators
Table 54. Key Market Challenges & Risks of Veterinary Immunomodulators
Table 55. Key Industry Trends of Veterinary Immunomodulators
Table 56. Veterinary Immunomodulators Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Veterinary Immunomodulators Distributors List
Table 59. Veterinary Immunomodulators Customer List
Table 60. Global Veterinary Immunomodulators Sales Forecast by Region (2027-2032) & (kg)
Table 61. Global Veterinary Immunomodulators Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (kg)
Table 63. Americas Veterinary Immunomodulators Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Veterinary Immunomodulators Sales Forecast by Region (2027-2032) & (kg)
Table 65. APAC Veterinary Immunomodulators Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (kg)
Table 67. Europe Veterinary Immunomodulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (kg)
Table 69. Middle East & Africa Veterinary Immunomodulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Veterinary Immunomodulators Sales Forecast by Type (2027-2032) & (kg)
Table 71. Global Veterinary Immunomodulators Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Veterinary Immunomodulators Sales Forecast by Application (2027-2032) & (kg)
Table 73. Global Veterinary Immunomodulators Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Zoetis, Inc. Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 75. Zoetis, Inc. Veterinary Immunomodulators Product Portfolios and Specifications
Table 76. Zoetis, Inc. Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Zoetis, Inc. Main Business
Table 78. Zoetis, Inc. Latest Developments
Table 79. Elanco Animal Health Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 80. Elanco Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
Table 81. Elanco Animal Health Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Elanco Animal Health Main Business
Table 83. Elanco Animal Health Latest Developments
Table 84. Boehringer Ingelheim Animal Health Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 85. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
Table 86. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Boehringer Ingelheim Animal Health Main Business
Table 88. Boehringer Ingelheim Animal Health Latest Developments
Table 89. MSD Animal Health Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 90. MSD Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
Table 91. MSD Animal Health Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. MSD Animal Health Main Business
Table 93. MSD Animal Health Latest Developments
Table 94. ImmunoVet Ltd. Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 95. ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolios and Specifications
Table 96. ImmunoVet Ltd. Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. ImmunoVet Ltd. Main Business
Table 98. ImmunoVet Ltd. Latest Developments
Table 99. Vetoquinol S.A. Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 100. Vetoquinol S.A. Veterinary Immunomodulators Product Portfolios and Specifications
Table 101. Vetoquinol S.A. Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Vetoquinol S.A. Main Business
Table 103. Vetoquinol S.A. Latest Developments
Table 104. Phibro Animal Health Corporation Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 105. Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolios and Specifications
Table 106. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. Phibro Animal Health Corporation Main Business
Table 108. Phibro Animal Health Corporation Latest Developments
Table 109. Ceva Sant? Animale Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 110. Ceva Sant? Animale Veterinary Immunomodulators Product Portfolios and Specifications
Table 111. Ceva Sant? Animale Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Ceva Sant? Animale Main Business
Table 113. Ceva Sant? Animale Latest Developments
Table 114. Biogenesis Bago Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 115. Biogenesis Bago Veterinary Immunomodulators Product Portfolios and Specifications
Table 116. Biogenesis Bago Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Biogenesis Bago Main Business
Table 118. Biogenesis Bago Latest Developments
Table 1. Veterinary Immunomodulators Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Immunomodulators Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Major Players of Topical
Table 6. Major Players of Others
Table 7. Global Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 8. Global Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Table 9. Global Veterinary Immunomodulators Revenue by Type (2021-2026) & ($ million)
Table 10. Global Veterinary Immunomodulators Revenue Market Share by Type (2021-2026)
Table 11. Global Veterinary Immunomodulators Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global Veterinary Immunomodulators Sale by Application (2021-2026) & (kg)
Table 13. Global Veterinary Immunomodulators Sale Market Share by Application (2021-2026)
Table 14. Global Veterinary Immunomodulators Revenue by Application (2021-2026) & ($ million)
Table 15. Global Veterinary Immunomodulators Revenue Market Share by Application (2021-2026)
Table 16. Global Veterinary Immunomodulators Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global Veterinary Immunomodulators Sales by Company (2021-2026) & (kg)
Table 18. Global Veterinary Immunomodulators Sales Market Share by Company (2021-2026)
Table 19. Global Veterinary Immunomodulators Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Veterinary Immunomodulators Revenue Market Share by Company (2021-2026)
Table 21. Global Veterinary Immunomodulators Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers Veterinary Immunomodulators Producing Area Distribution and Sales Area
Table 23. Players Veterinary Immunomodulators Products Offered
Table 24. Veterinary Immunomodulators Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Veterinary Immunomodulators Sales by Geographic Region (2021-2026) & (kg)
Table 28. Global Veterinary Immunomodulators Sales Market Share Geographic Region (2021-2026)
Table 29. Global Veterinary Immunomodulators Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Veterinary Immunomodulators Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Veterinary Immunomodulators Sales by Country/Region (2021-2026) & (kg)
Table 32. Global Veterinary Immunomodulators Sales Market Share by Country/Region (2021-2026)
Table 33. Global Veterinary Immunomodulators Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Veterinary Immunomodulators Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Veterinary Immunomodulators Sales by Country (2021-2026) & (kg)
Table 36. Americas Veterinary Immunomodulators Sales Market Share by Country (2021-2026)
Table 37. Americas Veterinary Immunomodulators Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 39. Americas Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 40. APAC Veterinary Immunomodulators Sales by Region (2021-2026) & (kg)
Table 41. APAC Veterinary Immunomodulators Sales Market Share by Region (2021-2026)
Table 42. APAC Veterinary Immunomodulators Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 44. APAC Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 45. Europe Veterinary Immunomodulators Sales by Country (2021-2026) & (kg)
Table 46. Europe Veterinary Immunomodulators Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 48. Europe Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 49. Middle East & Africa Veterinary Immunomodulators Sales by Country (2021-2026) & (kg)
Table 50. Middle East & Africa Veterinary Immunomodulators Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Veterinary Immunomodulators Sales by Type (2021-2026) & (kg)
Table 52. Middle East & Africa Veterinary Immunomodulators Sales by Application (2021-2026) & (kg)
Table 53. Key Market Drivers & Growth Opportunities of Veterinary Immunomodulators
Table 54. Key Market Challenges & Risks of Veterinary Immunomodulators
Table 55. Key Industry Trends of Veterinary Immunomodulators
Table 56. Veterinary Immunomodulators Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Veterinary Immunomodulators Distributors List
Table 59. Veterinary Immunomodulators Customer List
Table 60. Global Veterinary Immunomodulators Sales Forecast by Region (2027-2032) & (kg)
Table 61. Global Veterinary Immunomodulators Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (kg)
Table 63. Americas Veterinary Immunomodulators Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Veterinary Immunomodulators Sales Forecast by Region (2027-2032) & (kg)
Table 65. APAC Veterinary Immunomodulators Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (kg)
Table 67. Europe Veterinary Immunomodulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (kg)
Table 69. Middle East & Africa Veterinary Immunomodulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Veterinary Immunomodulators Sales Forecast by Type (2027-2032) & (kg)
Table 71. Global Veterinary Immunomodulators Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Veterinary Immunomodulators Sales Forecast by Application (2027-2032) & (kg)
Table 73. Global Veterinary Immunomodulators Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Zoetis, Inc. Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 75. Zoetis, Inc. Veterinary Immunomodulators Product Portfolios and Specifications
Table 76. Zoetis, Inc. Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Zoetis, Inc. Main Business
Table 78. Zoetis, Inc. Latest Developments
Table 79. Elanco Animal Health Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 80. Elanco Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
Table 81. Elanco Animal Health Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Elanco Animal Health Main Business
Table 83. Elanco Animal Health Latest Developments
Table 84. Boehringer Ingelheim Animal Health Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 85. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
Table 86. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Boehringer Ingelheim Animal Health Main Business
Table 88. Boehringer Ingelheim Animal Health Latest Developments
Table 89. MSD Animal Health Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 90. MSD Animal Health Veterinary Immunomodulators Product Portfolios and Specifications
Table 91. MSD Animal Health Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. MSD Animal Health Main Business
Table 93. MSD Animal Health Latest Developments
Table 94. ImmunoVet Ltd. Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 95. ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolios and Specifications
Table 96. ImmunoVet Ltd. Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. ImmunoVet Ltd. Main Business
Table 98. ImmunoVet Ltd. Latest Developments
Table 99. Vetoquinol S.A. Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 100. Vetoquinol S.A. Veterinary Immunomodulators Product Portfolios and Specifications
Table 101. Vetoquinol S.A. Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Vetoquinol S.A. Main Business
Table 103. Vetoquinol S.A. Latest Developments
Table 104. Phibro Animal Health Corporation Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 105. Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolios and Specifications
Table 106. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. Phibro Animal Health Corporation Main Business
Table 108. Phibro Animal Health Corporation Latest Developments
Table 109. Ceva Sant? Animale Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 110. Ceva Sant? Animale Veterinary Immunomodulators Product Portfolios and Specifications
Table 111. Ceva Sant? Animale Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Ceva Sant? Animale Main Business
Table 113. Ceva Sant? Animale Latest Developments
Table 114. Biogenesis Bago Basic Information, Veterinary Immunomodulators Manufacturing Base, Sales Area and Its Competitors
Table 115. Biogenesis Bago Veterinary Immunomodulators Product Portfolios and Specifications
Table 116. Biogenesis Bago Veterinary Immunomodulators Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Biogenesis Bago Main Business
Table 118. Biogenesis Bago Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Immunomodulators
Figure 2. Veterinary Immunomodulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Immunomodulators Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Veterinary Immunomodulators Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Immunomodulators Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Immunomodulators Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Immunomodulators Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injectable
Figure 13. Product Picture of Topical
Figure 14. Product Picture of Others
Figure 15. Global Veterinary Immunomodulators Sales Market Share by Type in 2026
Figure 16. Global Veterinary Immunomodulators Revenue Market Share by Type (2021-2026)
Figure 17. Veterinary Immunomodulators Consumed in Online Sales
Figure 18. Global Veterinary Immunomodulators Market: Online Sales (2021-2026) & (kg)
Figure 19. Veterinary Immunomodulators Consumed in Offline Sales
Figure 20. Global Veterinary Immunomodulators Market: Offline Sales (2021-2026) & (kg)
Figure 21. Global Veterinary Immunomodulators Sale Market Share by Application (2025)
Figure 22. Global Veterinary Immunomodulators Revenue Market Share by Application in 2026
Figure 23. Veterinary Immunomodulators Sales by Company in 2026 (kg)
Figure 24. Global Veterinary Immunomodulators Sales Market Share by Company in 2026
Figure 25. Veterinary Immunomodulators Revenue by Company in 2026 ($ millions)
Figure 26. Global Veterinary Immunomodulators Revenue Market Share by Company in 2026
Figure 27. Global Veterinary Immunomodulators Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Veterinary Immunomodulators Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 30. Americas Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 31. APAC Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 32. APAC Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 33. Europe Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 34. Europe Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 36. Middle East & Africa Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 37. Americas Veterinary Immunomodulators Sales Market Share by Country in 2026
Figure 38. Americas Veterinary Immunomodulators Revenue Market Share by Country (2021-2026)
Figure 39. Americas Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 40. Americas Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 41. United States Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Veterinary Immunomodulators Sales Market Share by Region in 2026
Figure 46. APAC Veterinary Immunomodulators Revenue Market Share by Region (2021-2026)
Figure 47. APAC Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 48. APAC Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 49. China Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 53. India Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Veterinary Immunomodulators Sales Market Share by Country in 2026
Figure 57. Europe Veterinary Immunomodulators Revenue Market Share by Country (2021-2026)
Figure 58. Europe Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 59. Europe Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 60. Germany Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 61. France Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Veterinary Immunomodulators Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 68. Egypt Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Veterinary Immunomodulators in 2026
Figure 74. Manufacturing Process Analysis of Veterinary Immunomodulators
Figure 75. Industry Chain Structure of Veterinary Immunomodulators
Figure 76. Channels of Distribution
Figure 77. Global Veterinary Immunomodulators Sales Market Forecast by Region (2027-2032)
Figure 78. Global Veterinary Immunomodulators Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Veterinary Immunomodulators Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Veterinary Immunomodulators Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Veterinary Immunomodulators Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Veterinary Immunomodulators Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Veterinary Immunomodulators
Figure 2. Veterinary Immunomodulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Immunomodulators Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Veterinary Immunomodulators Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Immunomodulators Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Immunomodulators Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Immunomodulators Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injectable
Figure 13. Product Picture of Topical
Figure 14. Product Picture of Others
Figure 15. Global Veterinary Immunomodulators Sales Market Share by Type in 2026
Figure 16. Global Veterinary Immunomodulators Revenue Market Share by Type (2021-2026)
Figure 17. Veterinary Immunomodulators Consumed in Online Sales
Figure 18. Global Veterinary Immunomodulators Market: Online Sales (2021-2026) & (kg)
Figure 19. Veterinary Immunomodulators Consumed in Offline Sales
Figure 20. Global Veterinary Immunomodulators Market: Offline Sales (2021-2026) & (kg)
Figure 21. Global Veterinary Immunomodulators Sale Market Share by Application (2025)
Figure 22. Global Veterinary Immunomodulators Revenue Market Share by Application in 2026
Figure 23. Veterinary Immunomodulators Sales by Company in 2026 (kg)
Figure 24. Global Veterinary Immunomodulators Sales Market Share by Company in 2026
Figure 25. Veterinary Immunomodulators Revenue by Company in 2026 ($ millions)
Figure 26. Global Veterinary Immunomodulators Revenue Market Share by Company in 2026
Figure 27. Global Veterinary Immunomodulators Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Veterinary Immunomodulators Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 30. Americas Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 31. APAC Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 32. APAC Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 33. Europe Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 34. Europe Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Veterinary Immunomodulators Sales 2021-2026 (kg)
Figure 36. Middle East & Africa Veterinary Immunomodulators Revenue 2021-2026 ($ millions)
Figure 37. Americas Veterinary Immunomodulators Sales Market Share by Country in 2026
Figure 38. Americas Veterinary Immunomodulators Revenue Market Share by Country (2021-2026)
Figure 39. Americas Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 40. Americas Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 41. United States Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Veterinary Immunomodulators Sales Market Share by Region in 2026
Figure 46. APAC Veterinary Immunomodulators Revenue Market Share by Region (2021-2026)
Figure 47. APAC Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 48. APAC Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 49. China Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 53. India Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Veterinary Immunomodulators Sales Market Share by Country in 2026
Figure 57. Europe Veterinary Immunomodulators Revenue Market Share by Country (2021-2026)
Figure 58. Europe Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 59. Europe Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 60. Germany Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 61. France Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Veterinary Immunomodulators Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Veterinary Immunomodulators Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Veterinary Immunomodulators Sales Market Share by Application (2021-2026)
Figure 68. Egypt Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Veterinary Immunomodulators Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Veterinary Immunomodulators in 2026
Figure 74. Manufacturing Process Analysis of Veterinary Immunomodulators
Figure 75. Industry Chain Structure of Veterinary Immunomodulators
Figure 76. Channels of Distribution
Figure 77. Global Veterinary Immunomodulators Sales Market Forecast by Region (2027-2032)
Figure 78. Global Veterinary Immunomodulators Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Veterinary Immunomodulators Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Veterinary Immunomodulators Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Veterinary Immunomodulators Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Veterinary Immunomodulators Revenue Market Share Forecast by Application (2027-2032)
